Loading ...

dutasteride-loaded (2-hydroxypropyl)-β-cyclodextrin nanoparticles

Based on

1 Articles
2013 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

(2-hydroxypropyl)-β-cyclodextrin

HP-β-CD
Type Complex Compound
Formula
Role carriers
2

dutasteride

Type Single Compound
Formula C27H30F6N2O2
Role loaded material

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
drug release

More information/entries available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
scanning electron microscopy

More information/entries available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
Sprague-Dawley rat

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • (2-hydroxypropyl)-β-cyclodextrin
  • dutasteride
  1. HYStqWky62wgsZX73M
  2. GBFpTnnYxpa4BE4g9vuigTy9Xqel
  3. hUMP
  4. AddoiX
Product

dutasteride-loaded (2-hydroxypropyl)-β-cyclodextrin nanoparticles

Size: 130.4 - 171.4 nm

Medium/Support: none

Method 2

Type: Physical formation
Source:
Starting materials
  • (2-hydroxypropyl)-β-cyclodextrin
  • dutasteride
  1. WCCgdMFBKkJsf4qm0Z
  2. qvZYV2GkeF23x4SHrnwFUuJc5JYz
  3. ptrN
  4. wG5F4d
Product

dutasteride-loaded (2-hydroxypropyl)-β-cyclodextrin nanoparticles

Size: 132.8 - 177.8 nm

Medium/Support: none

Method 3

Type: Physical formation
Source:
Starting materials
  • (2-hydroxypropyl)-β-cyclodextrin
  • dutasteride
  1. FVcPD4ZMm3wrpKKzc2
  2. qBeaQzfxuSw54jSUic5ONUISAbNo
  3. Shxn
  4. O8n1qU
Product

dutasteride-loaded (2-hydroxypropyl)-β-cyclodextrin nanoparticles

Size: 124.9 - 156.1 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial